---
title: "US FDA approves Humacyte’s Symvess for vascular trauma"
date: "2024-12-20T16:53:12.000Z"
publishedDate: "20 décembre 2024"
summary: "Humacyte recently shared that the US Food and Drug Administration (FDA) has granted a full approval for the Symvess acellular tissue-engineered vessel. A press release notes that Symvess is indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularisation is needed to avoid imminent limb loss, and when autologous [&#8230;] The post US FDA approves Humacyte&#8217;s Symvess for vascular trauma appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/us-fda-approves-humacytes-symvess-for-vascular-trauma/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-12-20-us-fda-approves-humacytes-symvess-for-vascular-trauma"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/us-fda-approves-humacytes-symvess-for-vascular-trauma/"
---

![US FDA approves Humacyte’s Symvess for vascular trauma](https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/us-fda-approves-humacytes-symvess-for-vascular-trauma/*

## L’essentiel

Humacyte recently shared that the US Food and Drug Administration (FDA) has granted a full approval for the Symvess acellular tissue-engineered vessel. A press release notes that Symvess is indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularisation is needed to avoid imminent limb loss, and when autologous [&#8230;] The post US FDA approves Humacyte&#8217;s Symvess for vascular trauma appeared first on Vascular News .

## Lien source

https://vascularnews.com/us-fda-approves-humacytes-symvess-for-vascular-trauma/
